Acadian Asset Management’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.91M Buy
757,710
+664,013
+709% +$2.42M ﹤0.01% 963
2026
Q1
$368K Buy
+93,697
New +$472K ﹤0.01% 1435
2024
Q4
– Sell
-6,089
Closed -$35K – 1955
2024
Q3
$35K Buy
+6,089
New +$40.3K ﹤0.01% 1896
2022
Q2
– Sell
-32,230
Closed -$151K – 1793
2022
Q1
$151K Buy
+32,230
New +$158K ﹤0.01% 1269
2017
Q4
– Sell
-38,705
Closed -$459K – 1638
2017
Q3
$459K Sell
38,705
-89,936
-70% -$1.33M ﹤0.01% 798
2017
Q2
$1.93M Buy
+128,641
New +$1.72M 0.01% 579

Other funds holding MDXG

Acadian Asset Management's MDXG Position: Q2 2026 in Review

Acadian Asset Management increased its MiMedx Group (MDXG) stake by 709% in Q2 2026, buying an estimated $2.42M and bringing the position to 757,710 shares worth $2.91M. The position accounts for ﹤0.01% of the portfolio, ranked #963.

Acadian Asset Management first reported a position in MDXG in Q2 2017 and has held it in 6 quarters since. 227 funds tracked by Wall St. Rank hold MDXG as of Q2 2026.

  • Acadian Asset Management held 757,710 shares of MiMedx Group worth $2.91M as of Q2 2026.
  • Acadian Asset Management bought 664,013 MiMedx Group shares in Q2 2026, an estimated $2.42M.
  • MiMedx Group made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #963 holding.
  • Acadian Asset Management first reported a position in MiMedx Group in Q2 2017 and has held it in 6 quarters since.
  • 227 funds tracked by Wall St. Rank held MiMedx Group as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.